NEW YORK--(BUSINESS WIRE)--Aurora Bio, Inc. www.Aurorabioinc.com today announced that data for the company’s novel PET radiotracer, AUR01, in development for systemic amyloidosis, has been accepted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback